🇺🇸

US SEC Filing Intelligence

· daily

DHS Homeland Security Contracts — September 10, 2026

In the period September 10, 2026, DHS awarded $612.9M across four contracts, all civilian, with a dominant theme of border security and IT modernization. The highest-conviction signal is OSI Systems' $88.1M fully-funded, firm-fixed-price delivery order for non-intrusive inspection systems, showing strong execution and long-term visibility. Accenture Federal Services' $370.1M cost-plus data center contract carries execution and foreign-ownership risk, while MAXIMUS and General Dynamics add stable, competitive wins. Key watch item: option exercises and DHS budget appropriations for FY2027-2029 will determine revenue durability.

4 total filings
· daily

VA Healthcare & Services Contracts — September 10, 2026

The September 10, 2026 VA Healthcare & Services contract stream totals $370.3 million across three awards, all civilian (0/3 defense-related), underscoring the Department of Veterans Affairs' sustained investment in cybersecurity, infrastructure, and energy efficiency. The highest-conviction signal is MAVERIS LLC's $217.8 million cybersecurity operations center delivery order (potential $331.2M with options), reflecting robust demand for VA cyber defense despite a neutral signal strength of 6/10. Key risks include firm-fixed-price execution exposure on long-duration contracts (MAVERIS through 2028, LEO A. DALY through 2027, UTILITY SYSTEMS SOLUTIONS through 2049) and the fact that UTILITY SYSTEMS SOLUTIONS has $0 outlayed to date, signaling potential funding or execution delays. The aggregate signal strength is neutral (5.0/10), with no bullish or bearish signals, indicating a steady but unremarkable procurement environment for VA services.

3 total filings
· daily

HHS & Healthcare Contracts Intelligence — September 10, 2026

This digest covers six HHS contracts totaling $1.31B, with only one defense-related award (ADVANCED TECHNOLOGY INTERNATIONAL at $1.01B), skewing the portfolio heavily toward civilian health R&D. The dominant theme is NIH/NIAID and BARDA funding for pandemic preparedness and biodefense, with five of six contracts supporting serological research, vaccine development, and medical countermeasure platforms. The highest-conviction signal is Leidos Holdings' $79.9M SeroNet win, which shows competitive strength in health R&D but represents a modest revenue contribution. Key risk: the $1.01B ADVANCED TECHNOLOGY INTERNATIONAL contract lacks pricing and competition details, creating opacity around its true profitability and competitive moat.

6 total filings
· daily

New Federal Contractors — September 10, 2026

This digest of 23 new federal contracts, totaling $2.83 billion, reveals a pronounced civilian agency spending bias, with only two defense-related awards. The Department of Health and Human Services (HHS) dominates, driven by a single $1.01 billion award to ADVANCED TECHNOLOGY INTERNATIONAL, which accounts for over a third of the total obligation and is the highest-conviction signal. While the aggregate is large, the signal strength is moderate (5.7/10), and the digest is characterized by neutral signals (16 of 23) and a lack of bearish flags. Key risks include the heavy concentration in HHS and the vulnerability of contracts awarded in late September to Continuing Resolution uncertainty. The most actionable bullish signal is OSI Systems' $88.1 million DHS award for border inspection systems, which offers high visibility and strong execution.

23 total filings
· daily

Significant Contract Modifications ($10M+) — September 10, 2026

This digest synthesizes 23 government contract modifications totaling $2.83 billion, predominantly from civilian agencies (21 of 23 contracts), with only two defense-related awards. The Department of Health and Human Services (HHS) dominates, led by a $1.01 billion sole-source award to ADVANCED TECHNOLOGY INTERNATIONAL, which accounts for 36% of aggregate value but lacks public revenue data, raising transparency concerns. The highest-conviction bullish signal is OSI Systems’ $88.1 million Rapiscan Systems delivery order from DHS/CBP for border inspection systems, with strong execution visibility and long-term service tail. Key risks include concentration in opaque or private entities (e.g., ADVANCED TECHNOLOGY INTERNATIONAL, INDEX ANALYTICS LLC) and potential budget disruption from Continuing Resolution uncertainty affecting October-December awards. Investors should monitor DHS border security spending, VA cybersecurity contract options, and NIH R&D pipeline for follow-on awards.

23 total filings
· daily

Contract Deobligations Alert — September 10, 2026

The 23 contracts totaling $2.83B are overwhelmingly civilian (21 of 23), with only 2 defense-related awards, signaling a continued shift toward civilian agency spending in health, homeland security, and infrastructure. The dominant theme is IT and cybersecurity services, led by a $1.01B HHS award to Advanced Technology International and significant DHS/CBP border security technology contracts to OSI Systems ($88.1M) and General Dynamics ($72.8M). The highest-conviction bullish signal is OSI Systems' fully-funded $88.1M delivery order with strong execution ($81M outlaid), while the key risk is the concentration of large awards in civilian agencies, which may face budget volatility under a continuing resolution. Watch for option exercises on the MAXIMUS TSA contract ($170.97M potential) and the General Dynamics surveillance contract ($115M potential) as key catalysts.

23 total filings
· daily

Contract Option Exercises — September 10, 2026

This digest of 23 contract option exercises totaling $2.83 billion reveals a pronounced civilian-agency tilt, with only 2 of 23 contracts defense-related, underscoring the current Continuing Resolution (CR) vulnerability for defense awards in the October-December window. The Department of Health and Human Services dominates, led by a $1.01 billion sole-source award to ADVANCED TECHNOLOGY INTERNATIONAL, which alone accounts for 36% of aggregate value and carries the highest materiality score (8/10). The highest-conviction bullish signal is OSI Systems' $88.1 million Rapiscan Systems border security win, reflecting durable DHS investment in non-intrusive inspection technology. Key risk: 16 of 23 contracts are neutral-rated, with 7 carrying medium pricing risk from firm-fixed-price structures, and the aggregate average signal strength of 5.7/10 suggests limited near-term catalysts for most contractors.

23 total filings
· daily

Federal Professional Services Contracts — September 10, 2026

The sole contract in this digest is a $52.96 million firm fixed-price award from the Department of Labor to Paragon Technical Services, Inc., a small disadvantaged and veteran-owned business, for administrative management consulting services. This is a civilian agency contract, with no defense-related awards in the period. The contract represents a significant revenue opportunity for Paragon, with a potential value of $67.70 million if all options are exercised, and signals stable demand for management consulting services within the Department of Labor. The highest-conviction signal is the multi-year revenue stream for Paragon, though the firm fixed-price structure introduces performance risk. Key watch items include the exercise of contract options and Paragon's execution under the fixed-price terms.

1 total filings
· daily

Federal IT & Cybersecurity Contracts — September 10, 2026

This digest covers $914.4 million in federal IT and cybersecurity contracts awarded between 2017 and 2025, with only 1 of 8 contracts defense-related (DHS/CBP), signaling a civilian-heavy stream. The dominant agency theme is Department of Health and Human Services (HHS/CMS), accounting for $141.6 million across three awards to INDEX ANALYTICS, CIVICACTIONS, and SPARKSOFT. The highest-conviction signal is MAXIMUS Federal Services’ $170.97 million TSA OPTIMA support contract, which reinforces its position in mission-critical DHS IT services. A key risk is the $370 million Accenture Federal Services DHS data center contract, where only $64 million has been outlayed and 55% is subawarded, raising execution and margin dilution concerns. Overall, the stream is neutral with 3 bullish signals, 0 bearish, and 5 neutral, reflecting stable civilian agency IT spending but limited defense exposure and modest profit upside due to fixed-price and cost-plus structures.

8 total filings
· daily

NASA & Space Contracts Intelligence — September 10, 2026

This single-contract digest covers a $47.7M non-competitive cost-plus-fixed-fee delivery order from NASA to the California Institute of Technology for terrestrial ecology and carbon cycle research, with no defense-related content. The award is purely civilian, aligning with NASA’s long-term Earth science priorities, but its low materiality (3/10) and neutral signal limit actionable investment insights. The key takeaway is that Caltech benefits from stable, low-risk revenue through 2027, though the lack of competition or commercial applicability reduces broader market relevance. A notable risk is the absence of competitive validation, which could mask inefficiency or budget vulnerability in future NASA science procurements. Given the N/A competition status, investors should watch for any shift toward competitive awards in NASA’s Earth science portfolio as a potential catalyst for other research contractors.

1 total filings
· daily

All HHS Contracts — September 10, 2026

The 9 HHS contracts totaling $1.46 billion reveal a civilian-heavy procurement stream overwhelmingly focused on health R&D and IT services, with only one defense-related award ($1.01B to ADVANCED TECHNOLOGY INTERNATIONAL) dominating the aggregate value. The dominant theme is NIH/NIAID and BARDA-funded biomedical research and pandemic preparedness, accounting for ~$304M across five contracts to Leidos Biomedical Research, BIOQUAL, Fisher Bioservices, JHU/APL, and Draper Laboratory. The highest-conviction signal is the $1.01B sole-source defense contract to ADVANCED TECHNOLOGY INTERNATIONAL, which represents 69% of total value but lacks pricing and competition details, creating significant uncertainty. Key risk: the ADVANCED TECHNOLOGY INTERNATIONAL award is opaque, and the remaining contracts are cost-plus with capped margins, limiting upside for investors despite stable revenue visibility.

9 total filings
· daily

Mega Contracts Monitor ($100M+) — September 10, 2026

The September 10, 2026 mega-contract stream (3 awards, $1.60B total) is entirely civilian, with zero defense-related obligations, underscoring sustained federal investment in IT and cybersecurity services across HHS, DHS, and VA. The dominant theme is large-scale civilian IT infrastructure and security spending, led by a $1.01B HHS award to Advanced Technology International (ATI) — the highest-conviction signal (bullish, 7/10) — while Accenture Federal Services' $370M DHS/CBP data center contract and Maveris LLC's $217.8M VA cybersecurity order add diversification but carry execution and pricing risks. Key watch items include the VA's $113.3M in unexercised options and the DHS contract's June 2023 end date, which may trigger recompetes. The absence of defense contracts suggests near-term DOD spending is not a driver in this stream, but civilian IT services remain a resilient growth pocket.

3 total filings
· daily

High-Value Federal Grants ($5M+) — September 10, 2026

The 23 high-value federal grants totaling $2.83 billion are overwhelmingly civilian, with only 2 defense-related contracts, signaling sustained non-defense spending in health, homeland security, and infrastructure. The Department of Health and Human Services (HHS) dominates, accounting for over half of the total value, led by a $1.01 billion award to Advanced Technology International. The highest-conviction signal is OSI Systems' $88.1 million DHS/CBP inspection systems contract, which shows strong execution with 92% of funds already outlaid. Key risks include the concentration of HHS awards, the potential for budget volatility under continuing resolutions, and execution risks on large fixed-price infrastructure contracts. Investors should watch for option exercises on MAXIMUS, General Dynamics, and Leidos contracts, as well as the re-compete of Accenture's DHS data center contract.

23 total filings
· daily

General Federal Contracts — September 10, 2026

This digest of 23 federal contracts, totaling $2.83 billion, reveals a pronounced civilian agency focus, with only 2 of 23 awards defense-related, underscoring a non-defense procurement cycle. The Department of Health and Human Services (HHS) dominates, led by a $1.01B award to ADVANCED TECHNOLOGY INTERNATIONAL, though data gaps limit its assessment. The highest-conviction bullish signals come from OSI Systems (Rapiscan) and General Dynamics, both securing border security contracts from DHS/CBP, indicating sustained investment in surveillance and inspection technology. A key risk is the high number of neutral signals (16 of 23), reflecting uncertainty from fixed-price contracts, small business set-asides, and long performance periods that may not translate to near-term shareholder value. Investors should watch for option exercises on the MAXIMUS and OSI Systems contracts as key catalysts, while monitoring execution risk on the large fixed-price awards to MAVERIS LLC and PARAGON TECHNICAL SERVICES.

23 total filings
· daily

All NASA Contracts — September 10, 2026

The sole contract in this digest is a $47.7 million cost-plus-fixed-fee delivery order from NASA to the California Institute of Technology (Caltech) for terrestrial ecology and carbon cycle research, spanning 2018-2027. This is a civilian agency award with zero defense-related content, reflecting NASA's continued investment in Earth science. The neutral signal (strength 5/10, materiality 3/10) indicates limited market implications due to the non-competitive nature and nonprofit recipient. Key risk is the lack of competitive validation and potential budget shifts in NASA's Earth science programs. The aggregate obligation of $47.7 million is modest, and the outlay rate of $35.4 million suggests steady funding flow but no near-term catalyst for investors.

1 total filings
· daily

S&P 500 Technology Sector SEC Filings — September 10, 2026

The S&P 500 Technology sector is in a period of aggressive AI-driven transformation, characterized by explosive revenue growth in cloud infrastructure and AI-adjacent hardware, but accompanied by significant margin compression and heavy capital expenditure. Broadcom's 85.5% YoY revenue surge and Oracle's 121% IaaS growth highlight the massive demand for AI compute, yet both companies face cash flow pressures and rising receivables. Meanwhile, Palo Alto Networks and Lam Research show concerning profitability declines despite top-line growth, signaling that the cost of AI investment is weighing on earnings. Insider activity is predominantly negative, with CEOs and directors at Datadog, Lam Research, and Arista Networks selling shares, though often under 10b5-1 plans, suggesting a lack of near-term conviction. Capital allocation is shifting towards debt financing for AI infrastructure (Oracle, Autodesk) and increased buybacks (Broadcom), while Adobe stands out as a positive outlier with strong growth, raised guidance, and a bullish sentiment. The sector is bifurcated between AI infrastructure winners (Broadcom, Oracle) and those facing margin erosion (Palo Alto, Lam Research), with investors needing to differentiate between top-line growth and sustainable profitability.

11 high priority 4 medium 15 total filings
· daily

Nasdaq 100 Stocks SEC Filings — September 10, 2026

The 18 filings from NASDAQ-100 constituents reveal a clear bifurcation: mega-cap tech leaders like Broadcom and Adobe are delivering exceptional revenue growth (85.5% and 13% YoY, respectively) and raising guidance, while a wave of insider selling—particularly concentrated in the semiconductor and AI infrastructure space—signals caution at elevated valuations. Broadcom's 10-Q shows explosive 117.3% product revenue growth and a tripling of net income, but trade receivables more than doubled, flagging potential collection risk. Adobe's 8-K highlights record Q3 revenue and a 150%+ YoY surge in AI-first ARR, with raised full-year targets. However, insider selling is pervasive: CoreWeave's CEO and GC sold a combined ~$11M in stock, Lam Research's CEO sold $9.6M, and Meta's COO sold $527K, all under 10b5-1 plans but at multi-month highs. The Broadcom S-4 and Arm AGM are low-materiality administrative events. Overall, the data suggests strong operational momentum in AI-driven names but a cautious insider posture that investors should monitor closely.

13 high priority 5 medium 18 total filings
· daily

S&P 500 Financials Sector SEC Filings — September 10, 2026

The 15 filings in this S&P 500 Financials digest reveal a sector dominated by routine insider transactions, with a notable concentration of director stock awards at MetLife (9 filings) and a cluster of pre-planned insider sales at Coinbase, Visa, JPMorgan, Robinhood, and AFLAC. The overall sentiment is neutral-to-negative, driven by the volume of insider selling (5 filings) versus routine awards (10 filings), though all sales were executed under Rule 10b5-1 plans, reducing their signaling potency. No period-over-period comparisons, forward-looking guidance, or capital allocation changes were present in any filing, limiting trend analysis. The most material event is a special servicer change at Morgan Stanley Capital I Trust 2020-L4, a low-materiality operational update. Key implications: the insider selling cluster in fintech and large-cap financials warrants monitoring, while MetLife's broad-based director awards suggest stable governance but no growth catalyst. The lack of earnings or guidance data makes this batch a low-actionability set, with focus shifting to upcoming earnings calls for JPMorgan and Visa.

13 high priority 2 medium 15 total filings
· daily

S&P 500 Energy Sector SEC Filings — September 10, 2026

The four filings in this digest reveal a bifurcated capital markets environment within the S&P 500 Energy sector. Williams Companies executed a $2.75 billion multi-tranche debt offering, capitalizing on favorable credit conditions to lock in long-term financing at rates between 5.0% and 6.4%, signaling a strategic move to strengthen its balance sheet and fund growth initiatives. ONEOK closed a $9 billion minority equity investment from Apollo, a landmark transaction that is credit-enhancing and provides substantial capital for expansion without diluting existing shareholders' voting power. Texas Pacific Land saw a nominal insider purchase by a 10% owner, a minor but positive signal of confidence. The overarching theme is a sector-wide push to secure low-cost capital, with companies leveraging both debt and equity markets to fund infrastructure and growth. The absence of period-over-period comparisons in these filings limits trend analysis, but the scale and structure of these capital raises underscore a strategic focus on financial flexibility and long-term positioning.

3 high priority 1 medium 4 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — September 10, 2026

The 8 filings from the S&P 500 Consumer Staples sector reveal a period of relative calm, dominated by routine director compensation (stock awards) at Procter & Gamble (PG) and minor insider transactions at Estee Lauder (EL) and Archer-Daniels-Midland (ADM). No period-over-period comparisons, forward-looking guidance, capital allocation changes, or M&A activity were present in any filing, indicating a quiet period devoid of major strategic shifts. The most notable signal is a director sale at Estee Lauder, which, while not massive, contrasts with the neutral/positive signal of stock awards at PG. The overall sector sentiment is neutral, with no earnings calls or major events scheduled in the immediate future based on the enriched data. The lack of guidance changes or operational metric updates suggests companies are in a holding pattern, likely awaiting Q3 earnings season for more substantive updates.

8 high priority 8 total filings